IP Library Granted Patent US 11,285,120
Granted Patent B2
US 11,285,120 · App. 16/179,370 · Granted Mar 29, 2022

Volatile organic compound formulations having antimicrobial activity

Inventors: Gary A. Strobel (Bozeman, MT); Bryan Blatt (Manhattan, MT)
Assignee: ECOPLANET ENVIRONMENTAL LLC
A61K31/19A01N37/02A01N37/12A61K31/22A61K36/062A61K47/44A23V2002/00Y02A50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,285,120
App. No.
16/179,370
Granted
Mar 29, 2022
Kind
B2
Abstract

The present invention includes novel chemical formulations having antimicrobial activity and their methods of use thereof. In some embodiments, the formulation further comprises at least one fungus.

Claims (26)

1. An antibacterial component having antibacterial activity, and consisting of an antibacterially effective amount of

a combination of isoamyl hexanoates and an acid selected from the group consisting of propanoic acid, isobutyric acid, and combinations thereof,

wherein the volume ratio of the acid to the isoamyl hexanoates in the combination is about 7:2.

2. A human or animal food composition comprising the antibacterial component of claim 1 .

3. A human or animal nutritional supplement comprising the antibacterial component of claim 1 .

4. A human food or animal feed supplement comprising the antibacterial component of claim 1 .

5. A human or animal health supplement comprising the antibacterial component of claim 1 .

6. An antibacterial human or animal waste treatment composition comprising the antimicrobial component of claim 1 .

7. A formulation comprising the antibacterial component of claim 1 , wherein the antibacterial effect of the component is present in the formulation regardless of whether any additional antimicrobial agent or other ingredient is included in the formulation.

8. A cleaning composition for reducing microbial growth on surfaces or instruments, or in areas, consisting of the formulation of claim 7 .

9. The cleaning composition of claim 8 , where the surfaces, instruments, or areas are located in one or more locations selected from the following: a medical facility; an agricultural plant; and a livestock facility.

10. The cleaning composition of claim 8 , suitable for use as a solution or spray for treating surfaces, instruments, or areas in one or more of the following: hospitals; home or restaurant or grocery food preparation areas; industrial food processing centers; and other locations where food is processed, stored, transported, or sold, and in which bacterial contamination may be a problem.

11. A cleaning composition for degrading, or deodorizing human or animal waste, comprising the component of claim 1 .

12. A cleaning composition for treatment of waste in one or more locations selected from the following: a latrine, cat litter box, animal stall, barn, chicken-raising facility, pig barn, pet station in a home, and zoo, comprising the antibacterial component of claim 1 .

13. A cleaning composition for treatment of waste in one or more locations selected from the following: a latrine, cat litter box, animal stall, barn, chicken-raising facility, pig barn, pet station in a home, and zoo, consisting of the formulation of claim 7 .

14. A pharmaceutical composition for treating a human or animal having a bacterial infection, comprising the antibacterial component of claim 1 .

15. A pharmaceutical composition for treating a human or animal having a microbial infection, consisting of the formulation of claim 7 .

16. A method of treating a human or animal having a bacterial infection, comprising the steps of

identifying a human or animal in need of such treatment,

and administering to that human or animal an oral or topical formulation comprising an effective amount of the antibacterial component of claim 1 .

17. A method of treating a human or animal having a bacterial infection, comprising the steps of

identifying a human or animal in need of such treatment,

and administering to that human or animal an effective amount of the formulation of claim 7 in the form of an oral or topical preparation.

18. The method of claim 16 , wherein the bacterial infection is caused by Escherichia coli, Staphylococcus aureus , or Salmonella.

19. The method of claim 17 , wherein the bacterial infection is caused by Escherichia coli, Staphylococcus aureus , or Salmonella.

20. The method of claim 17 , wherein the at least one acid in the combination is propanoic acid and isobutyric acid combined at a ratio of about 1:1 by volume.

Assignments (2)
CHANGE OF ADDRESS OF ASSIGNEE Recorded Feb 21, 2022
From: STROBEL, GARY A.; BLATT, BRYAN
To: ECOPLANET ENVIRONMENTAL LLC
Reel/Frame 059234/0228 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2021
From: STROBEL, GARY A.; BLATT, BRYAN
To: ECOPLANET ENVIRONMENTAL LLC
Reel/Frame 058335/0755 →
Continuity (2)
Continuation 14322757 · Jul 2, 2014
Related Publication 20190269634A1 · Sep 5, 2019